V. Latournerie

Most-cited papers

1. Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.

   C. Le Guiner, M. Montus, L. Servais, Y. Chérel +40 more

   2014Molecular Therapy119 citations Open access

   Semantic Scholar

   Save

2. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.

   David L. Mack, K. Poulard, M. Goddard, V. Latournerie +23 more

   2017Molecular Therapy102 citations Open access

   Semantic Scholar

   Save

3. Capsid-specific removal of circulating antibodies to adeno-associated virus vectors

   B. Bertin, Philippe Véron, C. Leborgne, J. Deschamps +14 more

   2020Scientific Reports79 citations Open access

   Semantic Scholar

   Save

4. Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.

   C. Leborgne, V. Latournerie, Sylvie Boutin, Diana Desgué +11 more

   2019Cellular Immunology47 citations Open access

   Semantic Scholar

   Save

5. Cyclo‐oxygenase and lipoxygenase pathways in mast cell dependent‐neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve

   G. Le Filliatre, S. Sayah, V. Latournerie, Jean-François Renaud +2 more

   2001British Journal of Pharmacology37 citations Open access

   Semantic Scholar

   Save

6. AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy.

   J. Dupont, Jian-Jun Guo, Edith Renaud-Gabardos, K. Poulard +7 more

   2019Molecular Therapy18 citations Open access

   Semantic Scholar

   Save

7. Leveraging Natural History Data in One- and Two-Arm Hierarchical Bayesian Studies of Rare Disease Progression

   A. Monseur, B. Carlin, B. Boulanger, A. Seferian +34 more

   2021Statistics in Biosciences3 citations Open access

   Semantic Scholar

   Save

8. G.P.92

   Laurent Servais, C. Le Guiner, M. Montus, Yan Cherel +31 more

   20142 citations

   Semantic Scholar

   Save

9. O.09 Gene therapy of spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME)

   J. Denard, M. Marinello, V. Latournerie, D. Bonnin +4 more

   2022Neuromuscular Disorders1 citations

   Semantic Scholar

   Save

10. 498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy

    Matthew Elverman, David L. Mack, M. Goddard, J. Snyder +14 more

    20160 citations Open access

    Semantic Scholar

    Save

11. Prolonged benefit from systemic rAAV8 in a canine model of myotubular myopathy

    Matthew Elverman, David L. Mack, K. Poulard, M. Goddard +10 more

    20160 citations

    Semantic Scholar

    Save

12. 503. Minimally Effective Dose of Systemic AAV8-MTM1 Needed To Prolong Survival and Correct Severe Muscle Pathology in a Canine Model of X-Linked Myotubular Myopathy

    David L. Mack, K. Poulard, M. Goddard, J. Snyder +20 more

    20150 citations Open access

    Semantic Scholar

    Save

13. Peripheral vein injection of AAV8-MTM1 leads to long-term survival and correction of severe muscle pathology in a canine model of X-linked myotubular myopathy: Results from a dose escalation study

    David L. Mack, K. Poulard, M. Goddard, Jessica M. Snyder +16 more

    20150 citations

    Semantic Scholar

    Save

14. [Arterial hypertension and unilateral small kidney].

    J. Vincent, V. Latournerie, A. Bodak

    1986Annales de medecine interne0 citations

    Semantic Scholar

    Save